About Us
Awards
History
Leadership
Board of Directors
Investors and Partners
Science
Pipeline
Anti-infectives Portfolio
Publications
Expanded Access
News & Events
Press Releases
In the News
Events
Careers
Open Positions
#venatorxcares
Contact
Publications
Science
Pipeline
Anti-infectives Portfolio
Publications
Expanded Access
Manuscripts
Click here for Access to the Journal Article
Click here for Access to the Journal Article
>> More Manuscripts
Posters
Rescue of Ceftibuten Activity by the Oral β-Lactamase Inhibitor VNRX-7145 against Enterobacteriaceae Expressing Class A, C and/or D β-Lactamases
Evaluation of the in vitro activity of cefepime plus VNRX-5133 and comparative agents against carbapenem-resistant Enterobacteriaceae.
Oral ceftibuten/VNRX-7145 shows equivalent activity in vitro to IV therapeutics against MDR Enterobacteriaceae.
Cefepime/VNRX-5133 Broad-Spectrum Activity is Maintained against Emerging KPC- and PDC-Variants in Multidrug Resistant K. pneumoniae and P. aeruginosa.
>> More Posters
You are using a browser that is not supported. Please consider changing your browser
